Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sogani

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapyR Motzer, G Bosl, R Heelan, et al.
Cancer|November 1, 1979
A critical analysis of response criteria in patients with prostatic cancer treated with cis-diamminedichloride platinum IIA Yagoda, R C Watson, R B Natale, et al.
Cancer|March 1, 1981
Adjuvant chemotherapy combination of vinblastine, actinomycin D, Bleomycin, and Chlorambucil following retroperitoneal lymph node dissection for stage II testis tumorD Vugrin, W F Whitmore, E Cvitkovic, et al.
British Journal of Urology|November 1, 1994
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancerA G Aprikian, W R Fair, V E Reuter, et al.
American Journal of Clinical Oncology|August 1, 1984
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumorsG J Bosl, A Yagoda, W F Whitmore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1985
VAB-6 as initial treatment of patients with advanced seminomaG F Stanton, G J Bosl, W F Whitmore, et al.
Progress in Clinical and Biological Research|January 1, 1990
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservationH Scher, H Herr, C Sternberg, et al.
The American Journal of Medicine|March 1, 1985
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsG J Bosl, A Yagoda, R B Golbey, et al.
The Journal of Urology|April 1, 1980
Flow cytometry in bladder cancer detection and evaluation using acridine orange metachromatic nucleic acid staining of irrigation cytology specimensL G Collste, Z Darzynkiewicz, F Traganos, et al.
British Journal of Urology|September 1, 1989
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimenH Scher, H Herr, C Sternberg, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1987
Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapyR Motzer, G Bosl, R Heelan, et al.
Cancer|November 1, 1979
A critical analysis of response criteria in patients with prostatic cancer treated with cis-diamminedichloride platinum IIA Yagoda, R C Watson, R B Natale, et al.
Cancer|March 1, 1981
Adjuvant chemotherapy combination of vinblastine, actinomycin D, Bleomycin, and Chlorambucil following retroperitoneal lymph node dissection for stage II testis tumorD Vugrin, W F Whitmore, E Cvitkovic, et al.
British Journal of Urology|November 1, 1994
Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancerA G Aprikian, W R Fair, V E Reuter, et al.
American Journal of Clinical Oncology|August 1, 1984
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumorsG J Bosl, A Yagoda, W F Whitmore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1985
VAB-6 as initial treatment of patients with advanced seminomaG F Stanton, G J Bosl, W F Whitmore, et al.
Progress in Clinical and Biological Research|January 1, 1990
M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) and bladder preservationH Scher, H Herr, C Sternberg, et al.
The American Journal of Medicine|March 1, 1985
Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumorsG J Bosl, A Yagoda, R B Golbey, et al.
The Journal of Urology|April 1, 1980
Flow cytometry in bladder cancer detection and evaluation using acridine orange metachromatic nucleic acid staining of irrigation cytology specimensL G Collste, Z Darzynkiewicz, F Traganos, et al.
British Journal of Urology|September 1, 1989
Neo-adjuvant chemotherapy for invasive bladder cancer. Experience with the M-VAC regimenH Scher, H Herr, C Sternberg, et al.
Pageof 3